A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)

Clinical trial NCT06185764 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06185764
Sponsor: Vertex Pharmaceuticals Incorporated
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myotonic Dystrophy Type 1 (DM1)

Start date: 2024-02-20
Primary completion: 2027-02-02
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.